(CAR) (Roelvink et al. 1998) . Biochemical analysis of CAR revealed that it is a 46 kDa glycoprotein widely distributed in human fibroblasts, glia, and to a lesser extent in the differentiated respiratory epithelium, mature skeletal muscle and human lymphocytes (Zabner et al. 1997; Walters et al. 1999; Nalbantoglu et al. 1999; Hidaka et al. 1999) . Less is known about CAR distribution in neuronal cells.
In this study we have used adenovirus serotype 5 to deliver DNA encoding the s1 GABA C receptor subunit into neuronal hippocampal cells. Recombinant adenovirus containing the s1 subunit (adeno-s) was produced under the human cytomegalovirus (CMV) promoter. Recombinant s1 GABA C receptors were expressed in 70-90 % of cultured hippocampal neurons after adeno-s infection. Patch-clamp analysis of GABA-activated current revealed that the s1 receptors had similar properties to s1 receptors expressed using standard transfection methods in non-neuronal cells. This finding could represent an important step towards the gene therapy of CNS receptor-related diseases.
METHODS

Molecular biology
The human s1 subunit and rat a1, b2 and y2 subunits were obtained from cDNA libraries via the polymerase chain reaction as described previously . The cDNA of the s1 subunit was excised using BamH I and Xba I restriction enzymes and inserted in the pShuttle CMV vector using Bgl II and Xba I ligation sites. Recombinant adenovirus containing s1 under the control of the human CMV promoter was produced using the QuantumAdEasy kit (Quantum Biotechnologies, Quebec, Canada) and has been termed adeno-s. Adeno-s was propagated in 10 9 HEK293 cells and was purified by centrifugation in a CsCl gradient according to Quantum protocols. The titre of infectious viral particles of adeno-s determined by plaque assay after large-scale purification was 2 w 10 11 plaque-forming units (PFU) ml _1 . Dialysed adeno-s was aliquoted and stored at _80°C.
Transfection. HEK293 cells were transfected with s1 and/or a1, b2 and y2 subunits in the pCDNA3 vector using Fugene 6 (Roche, Indianapolis, IN, USA) as described by the manufacturer. a1, b2 and y2 were cotransfected at a cDNA ratio of 1:1:2 with a total of 4 µg of cDNA per 35 mm dish. For the case of the cotransfection of s1, a1, b2 and y2 , the cDNA ratio was 1:1:1:2 with a total of 5 µg of cDNA per 35 mm dish. In all cases, 1 µg of green fluorescent protein (GFP) was included for visualization of transfected cells.
Primary culture of hippocampal neurons and cell infection
For preparation of dissociated neurons, Sprague-Dawley rats at stage P3-P5 (Harlan, Indianapolis, IN, USA) were rapidly decapitated after cervical dislocation, and the hippocampi were removed from the brain and dissected free of meninges in cooled (6°C), oxygenated, phosphate-buffered saline (PBS) containing Ca 2+ and Mg 2+ . This procedure, as well as the procedure for obtaining hippocampal slices (described below), were carried out under the guidelines and approval of the UAB Institutional Animal Care and Use Committee. The hippocampi were then transferred into Ca 2+ , Mg 2+ -free PBS, cut into small pieces and incubated with 0.3 % (w/v) protease from Aspergillus oryzae (Type XXIII; Sigma, St Louis, MO, USA) and 0.1 % (w/v) DNase (Type I, Sigma) for 20 min at 25°C. The tissue was washed and triturated. After a brief centrifugation, the cell pellet was resuspended in culture medium (minimal essential medium (MEM), Gibco BRL, Gaithersburg, MD, USA), supplemented with 10 % NU serum (Fischer Scientific, Pittsburgh, PA, USA), penicillin (5 U ml _1 ) and streptomycin (5 µg ml _1 ), and plated at a density of 8-10 (w 10 4 ) cells cm _2 on glass coverslips coated with poly-L-lysine. Cells were used after 10-14 days in culture.
Adeno-s was used at a concentration of 100 PFU cell _1 for the neuronal cultures, and in the range of 2 to 100 PFU cell _1 for the HEK293 and 911 cell lines. GABA-activated currents were recorded from 12 h to 5 days after infection.
Organotypic hippocampus slice culture and slice infection
Stage P7 Sprague-Dawley rats (Harlan) were cervically dislocated and rapidly decapitated. Hippocampal slices (200-400 µm thick) were prepared with a custom-designed wire slicer and maintained in vitro on Millicell-CM filter inserts (Millipore, Bedford, MA, USA) in a 36°C, 5 % CO 2 , humidified (99 %) incubator (Stoppini et al. 1991) . The concentration of horse serum (Gibco) in the culture medium was reduced from 20 to 10 % at 6 days in vitro. Over the next 2 days, serum was reduced to 5 % and then 0 %. The culture medium was completely exchanged every 3 days. The best infection of slices was observed in serum-free medium.
Electrophysiology
Experiments were performed at room temperature (20-24°C) using the whole-cell recording patch-clamp technique as previously described (Filippova et al. 1999) . The holding potential was _50 mV. The external recording solution contained (mM): NaCl, 160; KCl, 3.5; glucose, 10; CaCl 2 , 2; and Hepes, 10 (pH 7.4). In some experiments TTX (1 µM), DL-2-amino-5-phosphonopentanoic acid (DL-APV, 10 µM), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM) or bicuculline (30-50 µM) was added to the external bath solution to decrease spontaneous synaptic activity. The recording pipettes (borosilicate glass) had resistances of 3-5 MΩ when filled with internal solution containing (mM): CsCl, 150; CaCl 2 , 0.25; EGTA, 1.1 (free Ca 2+ , 5 w 10 _8 M); Hepes, 10; and Mg-ATP, 4 (pH 7.2). GABA, glycine and glutamate were applied to the cells through a doublebarrelled perfusion system. In some experiments, bicuculline (30-50 µM) was added in the GABA-containing solution. In order to determine the GABA A and GABA C current amplitudes in native neurons infected with adeno-s, the amplitude of the GABA A current was calculated by subtraction of the GABA C current amplitude (activated by 20 µM GABA in the presence of 50 µM bicuculline) from the current activated by 300 µM GABA without bicuculline. In the case of the s1 and s1-a1b2y2 coexpression studies in HEK293 cells, the amplitude of the GABA A current was calculated by subtraction of the GABA C current amplitude (activated by 10 µM GABA in the presence of 20 µM bicuculline) from the current activated by 200 µM GABA without bicuculline. Dose-response relationships were fitted with the following Hill equation using a non-linear least-squares method:
where I is the peak current response at a given concentration of agonist (A), I max is the maximum current response, EC 50 is the concentration of agonist with half-maximal activation, and n H is the Hill coefficient. Data were compared statistically by Student's t test. Statistical significance was determined at the 5 % level. All results are presented as means ± S.E.M.
N-terminal GABA C receptor antibodies N-terminal s1 GABA C receptor antibodies were raised against the GABA C receptor s1 subunit by synthesizing a fusion protein corresponding to the s1 N-terminal region (positions 14-191) with a 6 His tag on the N-terminus. The specific oligonucleotide primers used for the N-terminal fusion protein were as follows.
Forward primer (position 42-67): 5fi-CCACGCGGATCCGGCCAC TGAAAGCAGAATGCACTGG-3fi
Reverse primer (position 573-538): 5fi-GACTGAGCCCAAGCTTCTA CATTGCAGTTACTGTAACCCTGAGACTATAGAGCAC-3fi
The PCR product was subcloned, using BamH I and Hind III sites added to the primers, into the bacterial expression vector pQE-30 (Qiagen Inc., Valencia, CA, USA). The 6His fusion protein was expressed in Epicurian Coli BL21-Gold(DE3) pLysS cells (Stratagene, La Jolla, CA, USA) and was purified from urea-solubilized inclusion bodies by Ni-NTA chromatography (Qiagen) and then refolded. Mice were injected with the antigen and the serum was purified using an antigen-coupled, cyanogen bromide-activated column (Sigma). The mice were humanely killed at the end of the procedure, which was carried out under the guidelines and approval of the UAB Institutional Animal Care and Use Committee.
Gel electrophoresis and Western blot analysis
HEK293 cells expressing s1 were lysed in cell culture lysis reagent (Promega, Madison, WI, USA). The concentration of total cell protein was determined using a DC protein assay kit (Bio-Rad, Hercules, CA, USA) with bovine serum albumin as a standard. Total cell protein from HEK293 cells and bacterial fusion proteins were separated by SDS-PAGE, transferred to Hybond-P membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA) and detected using the ECL+Plus Western blotting detection system (Amersham Pharmacia Biotech). The following dilutions ofantibody were used: anti-N-terminal s1 GABA C receptor antibody, 1:500 for HEK293 cell lysates and 1:2000 for E. coli fusion proteins; secondary sheep antimouse Ig horseradish peroxidase-linked antibody (Amersham Life Sciences), 1:2000.
Immunocytochemistry and laser scanning confocal microscopy Slices or primary hippocampal cells were fixed overnight in 4 and 2 % paraformaldehyde in PBS solution, respectively, rinsed in PBS, incubated in blocking solution (10 % horse serum, 2 % bovine serum albumen in PBS), and then incubated overnight at 4°C in primary antibody (anti-N-terminal s1 GABA C receptor antibody, 1:200). Following washout of the primary antibody with PBS solution, slices or cells were incubated overnight with the secondary antibody (Texas Red-conjugated antibody, Amersham Life Sciences) and mounted.
Imaging was performed with a laser scanning confocal microscope (LSCM; Olympus Fluoview, Mellville, NY, USA). In some cases, to aid cell visualization, the membrane-permeable red fluorescent dye Ro31-8222 (Roche Molecular Biochemicals) was added to the external solution. Appropriate controls lacking primary and secondary antibodies were performed, and background fluorescence was adjusted for each experiment.
Drugs
The following drugs were used for the experiments: bicuculline, GABA, glutamate, glycine (all from Sigma), CNQX, DL-APV5, 3-aminopropylphosphonic acid (3-APA), (2S)(+)-5,5-dimethyl-2-morpholineacetic acid (SCH 50911) and trans-4-aminocrotonic acid (TACA) (all from Tocris, Ballwin, MO, USA). and HEK293 cells infected with adeno-s (2 and 10 PFU cell _1 , lanes 2 and 3, respectively). Note the specific band of the s1 subunit of the GABA C receptor (50 kDa) in lanes 2 and 3. C, whole-cell current evoked at a holding potential of _50 mV with GABA (10 µM) in the presence of bicuculline (30 µM) from HEK293 cells after adeno-s infection. Decay of the current upon GABA removal was well described by a single exponential component with a time constant (r) of 7 s. D, mean dose-response relationship for GABAactivated current fitted with a Hill equation (n = 4).
RESULTS
Characterization of recombinant s1 receptors in HEK293 cells after adeno-s infection
performed on HEK293 cells. Figure 1A demonstrates that the N-terminal s1 antibody recognized a bacterially synthesized N-terminal fusion protein of the human s1 subunit at a concentration of 20 and 2 ng. N-terminal s1 GABA C receptor antibodies did not recognize any specific proteins from untransfected HEK293 cells (Fig. 1B, lane  1) . However, we observed specific signals of the expected size for the s1 subunit of GABA C receptors in HEK293 cells 24 h after adeno-s infection at two different titres, 2 and 10 PFU cell _1 (Fig. 1B, lanes 2 and 3, respectively) . Figure 1C illustrates current activated by GABA application (10 µM) in the presence of bicuculline (30 µM) from HEK293 cells 24 h after adeno-s infection. The GABA-evoked current showed no desensitization, had a linear current-voltage relationship, and was insensitive to bicuculline (not shown). The time constant of decay upon GABA removal (deactivation) was 8 ± 1 s (Fig. 1C , n = 6). The GABA C receptor antagonist 3-APA (300 µM) completely and reversibly blocked this current (n = 3). Figure 1D is the mean dose-response relationship best fitted with the Hill equation yielding an EC 50 of 1 ± 0.3 µM, and a Hill coefficient of 2.6 ± 0.4 (n = 4).
These properties of recombinant s1 GABA C receptors after adeno-s infection are indistinguishable from those of s1 receptors in HEK293 cells after standard transfection protocols (Filippova et al. 1999) .
Pharmacological properties of current recorded from hippocampal neurons in culture before and after adeno-s infection
Before expressing s1 subunits, we first characterized the native ligand-activated current in uninfected neurons.
Based on these studies, we divided uninfected neurons into three groups according to the properties of the ligand-activated current (Fig. 2Ai-iii) . The first group (Fig. 2Ai) represented about 14 % (6/44 cells) of the cultured neurons tested and had GABA A receptors; that is, a GABA-activated current which was inhibited by bicuculline and had strong desensitization at high GABA concentrations (> 100 µM). The second group (Fig. 2Aii) represented 63 % (28/44 cells) of the neurons and had GABA A receptors similar to group i, but also exhibited a glutamate-activated current. Note that in both groups, GABA (10 µM) in the presence of bicuculline (30 µM) did not activate a current, confirming the absence of native Note that GABA (10 µM) in the presence of bicuculline (Bicuc; 30 µM) did not activate current from group i and ii neurons, but evoked a small current from group iii neurons. B, 3-APA (300 µM) did not block the bicuculline-insensitive current from neurons in group iii. SCH 50911 (SCH; 50 µM) was present to block GABA B receptors. C, the bicuculline-insensitive current from group iii neurons had a linear current-voltage relationship. D, examples of ligand-activated currents from neurons after adeno-s infection. Note that GABA (10 µM) in the presence of bicuculline (30 µM) evoked a GABA C -like current. E, 3-APA (300 µM) completely and reversibly blocked the bicuculline-insensitive current that appeared after adeno-s infection. F, dose-response relationship of bicuculline-insensitive current after adeno-s infection. Glyc, glycine; Glut, glutamate.
GABA C -like receptors. The third group of cells represented 23 % of the population (10/44 cells). In addition to the GABA A and glutamate currents as in group ii, these neurons contained a glycine-activated current (Fig. 2Aiii) . Moreover, GABA (10 µM) in the presence of bicuculline (30 µM) induced a current with an amplitude of 40-100 pA, a linear current-voltage relationship and fast deactivation (r < 1 s; Fig. 2C ). Unlike a GABA C receptor current, this current was not blocked by the GABA C competitive antagonist 3-APA (300 µM; Fig. 2B ). In fact, we observed a slight potentiation of this current in the presence of 3-APA and the GABA B antagonist SCH 50911. A similar potentiation was observed with 3-APA alone (data not shown). Our results suggest that rat hippocampal neurons do not express a classic GABA C -like current, although we have not yet identified the receptors responsible for the bicuculline-insensitive, GABA-activated current in neurons from group iii.
Two to three days after adeno-s infection, GABA (10 µM), in the presence of bicuculline (30 µM), induced a current with a linear current-voltage relationship, no desensitization and a slow deactivation rate (r = 6 ± 2 s, n = 24) in all three types of cell. Figure 2D shows currents from a type ii neuron after infection. Figure 2E demonstrates that 3-APA (300 µM) completely and reversibly blocked the bicuculline-insensitive GABAactivated current (n = 8), and the GABA agonist TACA (10 µM) evoked a current with the same amplitude as GABA (10 µM) with or without bicuculline (30 µM). To estimate the dose-response relationship, we applied GABA at different concentrations in the presence of bicuculline (30 µM; Fig. 2F ). The dose-response relationship was best fitted with a single Hill equation yielding an EC 50 of 1 ± 0.4 µM, and a Hill coefficient of 2.2 ± 0.4 (n = 4). These results confirm that recombinant s1 receptors were expressed in hippocampal neurons after adeno-s infection, and had similar properties to s1 receptors after infection of HEK293 cells (Fig. 1C and D) . (adeno-GFP). For cell visualization, the membranepermeable red fluorescent dye Ro31-8222 was added to the external solution 5 min prior to examination. Figure 3A (left) shows a dissociated hippocampal neuron infected with adeno-GFP (top, green fluorescence) and treated with Ro31-8222 dye (middle, red fluorescence). The two images are merged in the bottom panel of Fig. 3A . Confocal scanning microscopy revealed that 70-90 % of the neurons in the hippocampal culture had green fluorescence and, thus, this percentage of cells could be potentially targeted by adenovirus (Fig. 3B ). In the case of the HEK293 and 911 cell lines, all cells had green fluorescence and showed a cytopathic effect (Fig. 3C) .
To estimate the percentage of infectible neurons that express recombinant s1 GABA C receptors, we co-infected neuronal cells with both adeno-GFP and adeno-s. From 12 h to 4 days after infection, we analysed the current amplitude of recombinant s1 GABA C receptors activated by GABA (20 µM) in the presence of bicuculline (50 µM) and found that the amplitude of the GABA C current increased over this time course. Four days after infection, 100 % of the infected cells (about 90 % of all neurons) contained a GABA C current (Fig. 3D ). In the HEK293 and 911 cell lines, 100 % of the cells expressed recombinant s1 GABA C receptors 12 h after infection (Fig. 3D) . Figure 3E presents examples of GABA C -and GABA Aactivated currents in the hippocampal neurons 2 and 4 days after infection. The amplitude of the recombinant GABA C current on the second day of infection was 100-400 pA, which was 4-to 10-fold less than that of the typical GABA A current (1-2 nA). However, 4 days post-infection, the GABA C current amplitude reached 0.8-1.5 nA, while the GABA A current decreased to < 300 pA. The mean ratio between the GABA C and GABA A current amplitudes was 0.16 ± 0.05 (n = 10) and 8 ± 1 (n = 10) on the second and fourth days postinfection, respectively. We did not observe a significant change in the amplitude of the glutamate-activated current after s1 receptor expression (290 ± 70 and 210 ± 40 pA before and at 4 days post-adeno-s infection, respectively; n = 5).
We also observed a decrease in the expression level of a1b2y2 GABA A receptors transfected into HEK293 cells following infection with adeno-s. Seventy-two hours after transfection and 12 h after adeno-s infection, the amplitude of the a1b2y2 GABA A current was 335 ± 150 pA (n = 5) as compared to 1486 ± 600 pA (n = 5) without adeno-s infection. A qualitatively similar finding was observed when, rather than adeno-s infection, HEK293 cells were transfected with both s1 GABA C and a1b2y2 GABA A receptors. In this case, the GABA A current was 100 ± 80 pA (n = 4) as compared to 1486 ± 600 pA (n = 5) with a1b2y2 expression alone. Recombinant s1 GABA C receptors expressed in cultured hippocampal slices after adeno-s infection Cultured hippocampal slices were co-infected with both adeno-GFP and adeno-s. Three days after infection, slices were fixed and primary N-terminal s1 GABA C receptor and secondary Texas Red-conjugated antibodies antibodies were used for visualization of s1 GABA C receptors. Control non-infected slices did not exhibit specific antibody staining (not shown). However, we observed bright red fluorescence confirming the presence of s1 receptors on the cell surface 3 days after adeno-s infection (Fig. 4B) . Moreover, we observed a strong correlation between green and red fluorescence ( Fig. 4A-C) suggesting that adeno-GFP and adeno-s infected the same neurons.
To confirm the functional expression of s1 receptors, we employed the patch-clamp technique in the whole-cell recording configuration. In uninfected slices, we did not observe a native GABA C -like current (5/5 cells). However, in adeno-s1-infected neurons, GABA (10 µM) in the presence of bicuculline (30 µM) induced a current with a linear current-voltage relationship, and slow decay time (r > 10 s; 4 of 4 cells). As expected for GABA C receptors, the current was reversibly blocked by 3-APA (300 µM; n = 4; Fig. 4D ). Thus, recombinant s1 receptors were expressed in hippocampal slices after adeno-s infection.
DISCUSSION
We have demonstrated that recombinant s1 GABA C receptors could be expressed in hippocampal neurons after adeno-s infection and these receptors exhibited properties similar to those of recombinant s1 GABA C receptors previously described in HEK293 cells (Filippova et al. 1999) . Furthermore, the hippocampal neurons expressed s1 receptors regardless of their existing complement of ligand-activated receptors.
The distribution of s1 subunits has been identified by RT-PCR and in situ hybridization in the retina, superior colliculus, dorsal lateral geniculate nucleus and visual cortex (Boue-Grabot et al. 1998) . In our experiments, we did not observe specific immunostaining of hippocampal neurons using N-terminal s1 GABA C receptor antibodies, suggesting either the absence, or very low levels, of native GABA C receptors in the hippocampus. Overall, based on patch-clamp experiments and immunostaining, we conclude that s1 GABA C receptors are not evident in the rat hippocampus at P4-P8. The presence of other subunit combinations (s2, s3) of GABA C receptors cannot be confirmed or eliminated. Considering the native bicuculline-insensitive current that was not blocked by 3-APA (Fig. 2Aiii) , it is possible that GABA C receptor subunits interact with GABA A or glycine subunits, and form GABA-activated receptors with unexpected characteristics.
An interesting observation in our study was that expression of s1 GABA C receptors after adeno-s infection of hippocampal neurons diminished functional expression of GABA A receptors. Functional coassembly of the s1(T314A) GABA C subunit with the y2 GABA A receptor subunit was recently confirmed (Pan et al. 2000) . Moreover, the authors observed a dramatic decrease in the functional expression of GABA A and glycine receptors after co-expression with s1 GABA C receptors in Xenopus oocytes. It is possible that in native neurons, an interaction of recombinant s1 subunits with native y2 GABA A subunits could replace GABA A receptors with s1-y2 chimeric receptors. If this occurs, the interaction would not be evident functionally as the proposed wildtype s1-y2 receptor has properties indistinguishable from those of s1 alone (Pan et al. 2000) . Another possibility for the decrease in the GABA A receptor current after expression of GABA C receptors is that the GABA C receptors monopolize the translational machinery of the cells. This explanation seems unlikely, since the amplitude of the glutamate-activated current was unchanged after GABA C receptor expression.
During the review of our manuscript, a report appeared that also demonstrated expression of GABA C receptors by infection with an adenovirus containing the s1 subunit (Cheng et al. 2001) In addition to documenting functional expression, the authors demonstrated that expression of GABA C receptors eliminated neuronal hyperactivity and delayed the neuronal death induced by chronic blockade of glutamate receptors. One interesting difference between the two studies was that these authors noted an increased expression of GABA A receptors after infection with the s1 subunit as opposed to our observed decrease in GABA A expression. A possible explanation for this difference could be the choice of promoter. While we employed a CMV promoter, Cheng et al. (2001) used a promoter from Rous sarcoma virus (RSV). The promoter affects cell-type specificity, temporal patterns of expression and absolute expression levels (Smith et al. 2000) . Comparison of b-galactosidase or GFP expression under the control of different viral promoters in hippocampal neurons demonstrated a high expression level in pyramidal neurons and low expression in granule cells with CMV with the opposite pattern with the RSV promoter (Smith et al. 2000) . Furthermore, expression under the CMV promoter peaked rapidly and remained high, whereas the RSV promoter produced lower levels of b-galactosidase that began to decrease after several days in culture. These findings are confirmed with s1 as the highest level of expression Chen et al. (2001) could obtain with the RSV promoter without observing gross morphological abnormalities was an infection of 10-20 % of the cells, whereas we estimated ~70-90 % of the cells expressed GABA C -like currents with the CMV promoter. The choice of the expression vector could be an important consideration in the control of the levels of GABA C receptors as well as the desired spatial and temporal expression pattern within the central nervous system.
The successful example of the employment of adenovirus in the treatment of cystic fibrosis as well as carcinomas of various organs, including the lung, bladder, ovary and liver, is already well documented (Wilson, 1995; Eck et al. 1996) . The high infectional capabilities of adeno-s with respect to hippocampal neurons opens the way for gene therapy in the treatment of CNS-related diseases such as epilepsy. If the goal is to decrease neuronal excitability, the delivery of GABA C receptors composed of s1 subunits may be an optimal choice for several reasons. First, they have a higher sensitivity for GABA compared to GABA A receptors. Second, s1 receptors do not desensitize and they demonstrate a slow rate of deactivation upon agonist removal. Both of these factors could increase the efficiency of tonic inhibition of neurons in the presence of low concentrations of extracellular GABA. Finally, the structure-function relationship of s1 receptors has been well characterized allowing the use of custom-made s1 mutants with preferred properties.
